Evolving molecular subtyping of breast cancer advances precision treatment
Rui Shan, Lei-Jie Dai, Zhi‐Ming Shao, Yi‐Zhou Jiang
Abstract
Breast cancer is the second most prevalent cancer globally. In 2022, approximately 2.3 million newly diagnosed cases of female breast cancer occurred worldwide, and more than 665 thousand people lost their lives to this disease[1][1]. Understanding of breast cancer began with clinical observations
Topics & Concepts
SubtypingBreast cancerComputational biologyCancerComputer scienceMedicineOncologyInternal medicineBiologyProgramming languageComputational Drug Discovery MethodsMolecular Biology Techniques and ApplicationsGene expression and cancer classification